Company page

Thiogenesis Therapeutics Corp

Thiogenesis Therapeutics Corp, trading under the ticker TTI, is a public company based in Canada with a market capitalization of approximately CAD 21.5 million. The company focuses on developing innovative therapeutics to address unmet medical needs. Thiogenesis is committed to advancing its research and development efforts to bring new treatment options to market.